Jade Biosciences reported total assets of $472.11M and total liabilities of $32.20M for the quarter ended Jun 2026, up 110.8% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | |||||||||||||||||||||||||
| Receivables - AccuredAcc. Int. Receivables | 0.10M | 0.10M | |||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 180.90M | 54.20M | 161.10M | 152.00M | 142.60M | 22.40M | 118.90M | 150.10M | 135.20M | 23.49M | 99.30M | 104.20M | 88.70M | 69.39M | 76.20M | 220.94M | 50.11M | 88.44M | 55.10M | 107.25M | |||||
| Prepaid Assets | 2.22M | 6.96M | 4.81M | 1.46M | 2.58M | 2.28M | 1.64M | 2.37M | 2.40M | 1.79M | 3.90M | 6.56M | 1.88M | 0.27M | 1.16M | 2.04M | 2.46M | 12.66M | 7.22M | 10.05M | |||||
| Current Assets | 183.10M | 174.33M | 165.88M | 153.45M | 145.16M | 131.50M | 120.57M | 152.47M | 137.60M | 124.23M | 103.24M | 110.76M | 90.61M | 69.65M | 77.37M | 222.98M | 201.36M | 348.82M | 318.52M | 471.25M | |||||
| Non-Current Assets | |||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.16M | 0.19M | 0.29M | 0.32M | 0.33M | 0.24M | 0.27M | 0.24M | 0.32M | 0.29M | 0.26M | 0.23M | 0.01M | 0.00M | 0.15M | 0.18M | 0.17M | 0.16M | 0.14M | ||||||
| Other Non-Current Assets | 0.28M | 0.30M | 0.33M | 0.73M | 1.08M | 2.56M | 2.65M | 2.23M | 2.24M | 2.28M | 2.60M | 0.08M | 0.08M | 3.15M | 0.06M | 0.17M | 0.07M | 0.07M | 0.07M | ||||||
| Non-Current Assets | 1.02M | 1.03M | 1.11M | 2.23M | 2.50M | 3.81M | 3.82M | 3.29M | 3.27M | 3.19M | 3.58M | 0.93M | 0.35M | 3.15M | 0.16M | 0.98M | 1.09M | 0.96M | 0.92M | 0.86M | |||||
| Assets | 184.12M | 175.36M | 167.00M | 155.68M | 147.66M | 135.30M | 124.39M | 155.75M | 140.88M | 127.42M | 106.82M | 111.69M | 90.96M | 72.80M | 77.53M | 223.97M | 202.45M | 349.78M | 319.43M | 472.11M | |||||
| Liabilities | |||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||
| Accounts Payables | 2.56M | 1.21M | 2.86M | 2.07M | 4.54M | 2.58M | 4.73M | 5.53M | 3.50M | 2.40M | 3.31M | 4.18M | 0.91M | 1.29M | 0.07M | 7.59M | 1.35M | 2.15M | 3.98M | 6.58M | |||||
| Payables | 2.56M | 1.21M | 2.86M | 2.07M | 4.54M | 2.58M | 4.73M | 5.53M | 3.50M | 2.40M | 3.31M | 4.18M | 0.91M | 1.29M | 0.07M | 7.59M | 1.35M | 2.15M | 3.98M | 6.58M | |||||
| Accumulated Expenses | 1.12M | 1.15M | 1.65M | 1.34M | 2.79M | 4.82M | 5.54M | 7.38M | 10.77M | 14.82M | 11.76M | 12.37M | 8.95M | 4.12M | 2.04M | 8.09M | 14.01M | 9.42M | 14.85M | 14.92M | |||||
| Other Accumulated Expenses | 0.18M | 0.14M | 0.24M | 0.15M | 0.25M | 0.38M | 0.25M | 0.58M | 0.44M | 1.09M | 0.67M | 0.67M | 0.29M | 0.32M | 0.43M | ||||||||||
| Current Leases | 0.15M | 0.19M | 0.19M | 0.35M | 0.38M | 0.39M | 0.37M | 0.38M | 0.45M | 0.42M | 0.45M | 0.47M | 0.46M | 0.42M | 0.31M | ||||||||||
| Total Current Liabilities | 3.83M | 2.55M | 4.70M | 3.76M | 7.71M | 7.78M | 10.64M | 13.28M | 14.72M | 17.64M | 15.52M | 17.02M | 10.31M | 12.00M | 2.42M | 21.62M | 22.36M | 16.54M | 22.29M | 31.57M | |||||
| Non-Current Liabilities | |||||||||||||||||||||||||
| Convertible Debt | 107.60M | ||||||||||||||||||||||||
| Preferred Stock Liabilities | 0.00M | 0.00M | 0.00M | 0.00M | |||||||||||||||||||||
| Minority Interest | |||||||||||||||||||||||||
| Operating Leases | 0.60M | 0.38M | 0.53M | 1.21M | 0.80M | 0.70M | 0.59M | 0.48M | 0.36M | 0.26M | 0.33M | 0.21M | 0.08M | 0.80M | 0.75M | 0.72M | 0.70M | 0.63M | |||||||
| Other Non-Current Liabilities | 0.01M | 0.01M | 0.01M | 0.01M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | |||||||||||
| Total Non-Current Liabilities | 2.93M | 5.04M | 4.62M | 8.51M | 8.49M | 11.23M | 13.76M | 15.08M | 17.89M | 15.85M | 17.23M | 10.40M | 119.53M | 2.42M | |||||||||||
| Total Liabilities | 4.28M | 2.94M | 5.05M | 4.63M | 8.52M | 8.56M | 11.30M | 13.83M | 15.15M | 17.96M | 15.92M | 17.30M | 10.47M | 119.60M | 2.49M | 22.41M | 23.10M | 17.26M | 22.97M | 32.20M | |||||
| Shareholder's Equity | |||||||||||||||||||||||||
| Common Equity | 179.85M | 172.42M | 161.95M | 151.05M | 139.14M | 126.74M | 113.09M | 141.93M | 125.72M | 109.46M | 90.90M | -0.59M | -16.86M | -46.80M | -83.51M | 201.56M | 179.35M | 332.52M | 296.46M | 439.92M | |||||
| Liabilities and Shareholders Equity | 184.12M | 175.36M | 167.00M | 155.68M | 147.66M | 135.30M | 124.39M | 155.75M | 140.88M | 127.42M | 106.82M | 111.69M | 90.96M | 72.80M | 77.53M | 223.97M | 202.45M | 349.78M | 319.43M | 472.11M | |||||
| Retained Earnings | 208.01M | 208.87M | 209.89M | 211.13M | 212.79M | 215.11M | 217.72M | 265.59M | 268.93M | 272.64M | 277.54M | 305.86M | 307.89M | -46.98M | 310.56M | 318.86M | 321.77M | 506.77M | 511.55M | 711.09M | |||||
| Preferred Shares | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | ||||||||||||||||||||
| Treasury Shares | 0.23M | 0.23M | 0.23M | 0.23M | 20.00M | 20.00M | 20.00M | 20.00M | 6.61M | 6.26M | 6.17M | 6.26M | 5.98M |